Company / Profit Margin
Caribou Biosciences, Inc. Profit Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-1327.4%
FY2025
5-year range
-1327.4% / -296.1%
FY2021-FY2025
Trend
-348.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin changed -348% YoY in FY2025, a notable deviation from the 4-year average annual change of -91%.
Based on SEC 10-K filings.
-1327.4% in FY2025 with a 3-year CAGR of -630.1%.
Declined from -717.8% to -1327.4% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -630.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin decreased 348.4% year-over-year.
- Peak profit margin was recorded in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.99 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1327.4% | -348.4% |
| FY2024 | -296.1% | +58.8% |
| FY2023 | -717.8% | -2.9% |
| FY2022 | -697.3% | -72.2% |
| FY2021 | -404.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026